Interstitial lung diseases (ILD) are a group of disorders characterised by progressive scarring of lung tissue. This impairs the ability of the lungs to take up oxygen and leads to symptoms of breathlessness and cough. The KBILD questionnaire will help you and your healthcare professional measure the impact your ILD is having on your wellbeing and daily life. This can be used to monitor your condition and assess how well your treatment is working. The KBILD is a brief 15 item questionnaire and is validated, published and used in 24 countries1. It is intended to be completed regularly with each clinic visit or at home but you can complete it more frequently (for example every 3 months).Patel, A.S., Siegert, R.J., Brignall, K., Gordon, P., Steer, S., Desai, S.R., Maher, T.M., Renzoni, E.A., Wells, A.U., Higginson, I.J. and Birring, S.S., 2012. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax, 67(9), pp.804-810.
By completing this questionnaire, you are consenting to the inclusion of your data (for example, age, gender, diagnosis, KBILD score) for research purposes in future. Your data is anonymised, we do not ask for your name. This research could help advance our knowledge of the impact of ILD on patients’ wellbeing and improve the evaluation of new treatments. If you provide your email address, we may contact you in future about new developments in ILD and opportunities to participate in ILD research.
We are committed to safeguarding the privacy of our website visitors. We may collect, store and use the following kinds of personal information: (a) Information that you can provide to use when registering with our website (including [age, gender, lung diagnosis, medications and rheumatology condition]). (b) No identifiable information will be requested during the completion of this questionnaire.
The KBILD questionnaire is available in the following languages for research by email requests to firstname.lastname@example.org. MAPI certified translations: France, Germany, Spain, Italy, Netherlands, Australia, Belgium (French and Dutch), Canada (French and English) Chile (Spanish), China (Simplified Chinese), Japan, New Zealand, Poland, Russia, United States (English and Spanish), Argentina (Spanish), Korea, Norway, Czech Republic, Hungary, Israel (Arabic, Hebrew, Russian). KBILD is protected by copyright ©2012, Professor S. Birring. The KBILD in this website is intended for personal use by patients only.
We recommend you complete this questionnaire again in future as this will allow you and your healthcare professional to monitor your quality of life throughout the year and over longer periods. This can help improve the assessment of your ILD and the impact of treatments.
KBILD is protected by copyright © 2012, Professor S. Birring. For use of the KBILD in clinical trials or studies please email; email@example.com